Lazard Asset Management LLC Relay Therapeutics, Inc. Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 818 shares of RLAY stock, worth $3,926. This represents 0.0% of its overall portfolio holdings.
Number of Shares
818
Previous 61,424
98.67%
Holding current value
$3,926
Previous $400,000
98.75%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RLAY
# of Institutions
203Shares Held
156MCall Options Held
207KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$134 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$69.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$50.6 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$44.4 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$35.4 Million0.88% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $577M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...